abrdn Life Sciences Investors

abrdn Life Sciences Investors is a closed-end fund that focuses on the life sciences sector. The fund seeks long-term capital appreciation by investing primarily in equity and equity-related securities of U.S. and foreign companies involved in biotechnology, pharmaceuticals, diagnostics, medical devices, healthcare information services, and related healthcare subsectors. It also may include exposure to selected companies connected to agriculture and environmental management, broadening its reach beyond traditional healthcare. Managed by abrdn, the fund gives investors access to a diversified portfolio built around scientific innovation, drug development, research tools, and specialized healthcare services. As a life sciences-focused investment vehicle, abrdn Life Sciences Investors serves a niche role in the market by concentrating on companies tied to medical and scientific advances.